Form 10-Q SCICLONE PHARMACEUTICALS For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Sciclone Pharma (SCLN) Reports Q3 EPS of $0.26
November 10, 2015 7:56 AM ESTSciclone Pharma (NASDAQ: SCLN) reported Q3 EPS of $0.2, versus $0.17 reported last year. Revenue for the quarter came in at $42.9 million, versus $34.3 million reported last year.
For earnings history and earnings-related data on Sciclone Pharma (SCLN) click here.
... More